Thrombophilia and recurrent pregnancy loss.
Many unanswered questions regarding thrombophilia and recurrent pregnancy loss exist. For example, does a true association exist? Are thrombotic mechanisms relevant? Is a second messenger necessary to cause the manifestation of thrombosis? At present it seems that thrombophilia are associated with and may even cause some cases of pregnancy loss. The role of treatment remains to be determined. Although the aim of physicians working in this field is entirely laudable, to allow childless couples to have children, it is necessary to have good evidence of effect before treatment is given to all patients. A serious ethical dilemma remains, however, namely should treatment that may be effective be denied to patients who have prior pregnancy losses? Denial of treatment is extremely distressing for the patient and the physician. The author's own practice is to offer treatment after a full explanation, particularly because treatment is generally prescribed in the antiphospholipid syndrome and justified in hereditary thrombophilias according to the report of Carp and colleagues, showing a 25% improvement in live birth rates in treated patients. When treatment fails, however, the embryo should be karyotyped to exclude chromosomal aberrations.
Carp
Howard J A
HJ
Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, 52621 Israel, Tel Aviv University, Ramat Aviv, 69978, Israel. carp@netvision.net.il
D000026:Abortion, Habitual / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control; D000925:Anticoagulants / Q000627:therapeutic use; D017209:Apoptosis; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006728:Hormones; D006801:Humans; D010920:Placenta / Q000473:pathology; D011247:Pregnancy; D011379:Prognosis; D019851:Thrombophilia / Q000150:complications* / Q000188:drug therapy
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006728:Hormones